MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.pcad.2026.10.004

Медицинская библиотека · Progress in cardiovascular diseases · 2026

Factors affecting serum neurofilament light chain in transthyretin amyloid cardiomyopathy.

Davis Bryton, Zhao Yuanzi, Jahan Israt, Volk Hailey, Chahin Nizar, Masri Ahmad

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

While serum neurofilament light chain (sNfL) has shown promise as a biomarker for the development of peripheral neuropathy (PN) in hereditary transthyretin (TTR) amyloidosis (vATTR), its role in all-comers with ATTR cardiomyopathy (ATTR-CM) is less well defined, and it is unknown how CM severity and TTR stabilizer therapy affect sNfL.

METHODS

Study participants included those with ATTR-CM not on gene-silencer therapy referred to Oregon Health & Science University. The association between sNfL and baseline patient characteristics, including age, sex, body mass index (BMI), presence of PN, ATTR subtype, N-terminal pro b-type natriuretic peptide (NT-proBNP), estimated glomerular filtration rate (eGFR) and tafamidis treatment, were evaluated utilizing linear regression.

RESULTS

66 patients (age: 78.5 ± 6.9 years, 6.1% female, 16.7% with diabetes mellitus, 10.6% vATTR-CM, 43.9% with PN symptoms, 30.3% receiving tafamidis at baseline) were included. There was no difference in sNfL levels when stratified by ATTR subtype (p = 0.168), PN symptoms (p = 0.881), or tafamidis treatment measured categorically (p = 0.418). In 17 patients (17.6% vATTR-CM) with available paired pre-tafamidis and on-tafamidis samples, there was no difference in sNfL level. In our univariable and multivariable analysis, NT-proBNP and eGFR were associated with sNfL.

CONCLUSIONS

In ATTR-CM, cardiomyopathy severity and renal dysfunction impact sNfL more than presence of PN or other clinical factors.

Для цитирования: Davis Bryton, Zhao Yuanzi, Jahan Israt, Volk Hailey, Chahin Nizar, Masri Ahmad. Factors affecting serum neurofilament light chain in transthyretin amyloid cardiomyopathy.. Progress in cardiovascular diseases. 2026. DOI: 10.1016/j.pcad.2026.10.004.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.